Introduction
couple to more than one G protein subtype, their activation will initiate multiple effector systems, which hampers The mechanisms by which G protein-coupled receptors unraveling of the downstream biochemical pathways. activate the mitogen-activated protein (MAP) kinase casIn Rat-1 cells, however, LPA-and thrombin-induced cade are not well defined. Pertussis toxin (PTX)-sensitive activation of the MAP kinase pathway is mediated solely G i -coupled receptors, such as those for lysophosphatidic by G i -regulated Ras activation, with no detectable contriacid (LPA), thrombin and α2-adrenergic agonists, initiate bution of the PLC/Ca 2ϩ /PKC pathway (Alblas et al., 1993 ; a pathway that involves stimulation of Ras-GTP accumulavan Corven et al., 1993; Hordijk et al., 1994) . tion through intermediate tyrosine kinase activity (Alblas In this study, we set out to further investigate the et van Corven et al., 1993; Hordijk et al., 1994;  signaling pathway that couples G i to Ras-dependent MAP Moolenaar, 1995a; van Biesen et al., 1995; kinase activation. Using Rat-1 fibroblasts and COS cells, 1996) . Recent studies have identified βγ subunit released we show that G i -mediated MAP kinase activation requires from G i as the primary initiator of this pathway (Crespo neither Src nor Shc. We report the detection of a 100 kDa et Koch et al., 1994) .
tyrosine-phosphorylated protein, p100, that preferentially Several candidate tyrosine kinases have been proposed to serve as intermediaries between G i and Ras/MAP kinase binds to the C-terminal SH3 domain of Grb2 following LPA or thrombin stimulation. Our findings suggest a model in which the p100-Grb2 complex, together with an upstream non-Src tyrosine kinase and a wortmanninsensitive PI 3-kinase, links G i to Ras/MAP kinase activation, with Src and Shc functioning in a separate pathway.
Results

Agonist-induced MAP kinase activation: effects of tyrosine kinase inhibitors and wortmannin
In Rat-1 cells, LPA-and thrombin-induced activation of Ras and the downstream MAP kinase cascade is inhibited by genistein and stauroporine at doses that have little or no effect on EGF-induced Ras/MAP kinase activation Hordijk et al., 1994) . We assessed the specificity and dose dependence of these inhibitors in COS-7 cells transfected with epitope-tagged MAP kinase and stimulated by either LPA or EGF. As shown in Figure 1A , LPA-induced MAP kinase activation is much more sensitive to genistein than is the response to EGF: at a dose (10 μM) that inhibits the response to LPA by Ͼ80%, EGF action is virtually unaffected. Similarly, staurosporine inhibits LPA signaling approximately five times more potently than EGF signaling ( Figure 1B ). We also tested the effect of the PI 3-kinase inhibitor wortmannin (Wymann et al., 1996) . Wortmannin inhibits LPA-induced MAP kinase activation in COS cells with an IC 50 of~10 nM, whereas the response to EGF is much less affected ( Figure 1C ). We found that in Rat-1 cells, wortmannin inhibits LPA-induced MAP kinase activation with a similar IC 50 value to that in COS cells (data not shown). These results support the notion that G i -mediated Ras/MAP kinase activation involves both a protein tyrosine kinase and a wortmannin-sensitive PI 3-kinase. has no detectable effect on LPA-and EGF-induced MAP kinase activation ( Figure 2C ), despite high expression We also tested the effect of endothelin, which strongly activates the PLC/Ca 2ϩ /PKC pathway (van der Bend et al., levels of Src(K295M) (not shown); in parallel assays the inhibitory effect of dominant-negative Ras (RasN17) was 1992) but fails to stimulate Ras-GTP accumulation and MAP kinase activation in Rat-1 cells (van Corven et al., readily observed ( Figure 2C ). Likewise, LPA-induced MAP kinase activity in Rat-1 cells stably expressing 1993; Hordijk et al., 1994) . As shown in Figure 2B , endothelin is even more effective than LPA in stimulating dominant-negative Src was not detectably inhibited ( Figure  2D ), whereas Src-mediated gap junction closure was the association of c-Src with p110 and p130, whereas the peptide does not detectably activate MAP kinase. PTX completely prevented by this Src mutant (F.Postma, T.Hengeveld, J.Alblas, G.Zondag and W.Moolenaar, subpre-treatment of the cells did not inhibit Src-p110-p130 association induced by either LPA or endothelin (not mitted for publication). Furthermore, we used fibroblasts derived from mice that lack c-Src (Bockholt and Burridge, shown).
Agonist-induced Src activation: uncoupling from
To abrogate endogenous Src signaling, we used a kinase-1995). In these Src-deficient cells, LPA-induced MAP kinase activation is readily detectable (as is the response inactive c-Src mutant (K295M mutation; Roche et al., 1995) , which should act in a dominant-negative manner to peptide growth factors; Figure 2E ). Taken together, . Simultaneously, 50 μg total lysate were analyzed for MAP kinase activation by mobility shift assay (lower panel). Endothelin induces a much stronger increase in Src-p110-p130 complex formation than does LPA, but fails to activate MAP kinase. (C) COS cells were co-transfected with pEXVmycERK2 and either pCMV-lacZ (control), pMT2-N17Ras or pMT2-K295Msrc. After serum starvation (overnight), cells were stimulated with LPA and MAP kinase activity was determined as in Figure 1 . The data are means of three independent transfection experiments, all performed in duplicate. Clearly, LPA-induced MAP kinase activation critically depends on Ras but not Src.
(D) Stable cell lines transfected with either control vector or pMT2-src(K295M) (dn c-src) were incubated in serum-free medium and stimulated with LPA (5 min). MAP kinase activation was analyzed by mobility shift assay. Three different K295MSrc-expressing cell lines were tested and all three showed comparable MAP kinase activation in response to LPA. A representative experiment is shown. (E) MAP kinase activation in Src-deficient fibroblasts (Bockholt and Burridge, 1995) , analyzed by mobility shift assay. Concentrations used: LPA, 10 μM; EGF, 50 ng/ml; PDGF, 100 ng/ml.
these results indicate that Src does not function in G i - Figure 3 also shows that wortmannin has no effect on Shc mediated Ras/MAP kinase activation.
phosphorylation induced by either LPA or EGF.
In contrast to what is observed in COS cells, LPAinduced Shc phosphorylation in Rat-1 cells is not detectTyrosine phosphorylation of Shc: uncoupling from able under conditions where the response to EGF is G i -mediated MAP kinase activation and pronounced ( Figure 3 , left panels). To further assess the dependence on Ca 2⍣ role of Shc, we used a mutant version of Shc consisting Tyrosine-phosphorylated Shc has been implicated in G iof the isolated SH2 domain, designed to compete with mediated Ras signaling by virtue of its ability to bind the endogenous Shc for binding to upstream tyrosine-phosGrb2-Sos complex Chen et al., phorylated proteins (Baldari et al., 1995) . Transfection of 1996; . As shown in Figure 3 (right Shc-SH2 into COS cells attenuates EGF-induced MAP panel), stimulation of COS cells with either LPA or EGF kinase activation by~50%, without affecting the response causes rapid tyrosine phosphorylation of the three Shc to LPA (Figure 4 ). protein isoforms (p46, p52 and p66). However, preWe next examined whether Shc may function in the treatment of the cells with PTX has no effect on LPA-PTX-resistant G q -mediated PLC/Ca 2ϩ /PKC pathway. induced Shc phosphorylation, whereas MAP kinase activation is completely inhibited (Figure 3 , right panels). Figure 5A shows that both phorbol ester and the Ca 2ϩ ionophore ionomycin induce tyrosine phosphorylation of Shc. When intracellular stores are depleted of Ca 2ϩ by treatment with either thapsigargin or ionomycin/EGTA, LPA-induced Shc phosphorylation is inhibited ( Figure  5B ); in contrast, EGF-induced Shc phosphorylation is not affected in Ca 2ϩ -depleted cells ( Figure 5C ). Thus, Ca 2ϩ signaling is required for LPA-induced, but not EGFinduced Shc phosphorylation. Chronic phorbol ester treatment, in an attempt to down-regulate PKC, stimulated Shc phosphorylation to the same extent as acute treatment ( Figure 5B and results not shown), suggesting that PKC If Shc is not involved in G i -mediated Ras signaling, which tyrosine phosphorylation event links G i to the recruitment of Grb2? To answer this question we set out to identify Grb2 in response to LPA stimulation ( Figure 6A ). Using GST alone, no specific signals were detected (not shown). Grb2 binding proteins. Cellular proteins that bind to GSTGrb2 fusion proteins were purified on glutathione beads If p100 functions in the G i /Ras pathway, its association with Grb2 should be sensitive to PTX. Indeed, preand analyzed by anti-phosphotyrosine immunoblotting. Using this protocol, we detected a tyrosine-phosphorylated treatment of the cells with PTX prevents the interaction between Grb2 and p100 ( Figure 6A ). In addition to LPA, protein of 100 kDa, termed p100, that associates with treated with PTX or left untreated. The GST proteins were isolated on (A) Serum-starved COS cells were incubated with either PdBU glutathione beads and were analyzed by anti-phosphotyrosine Western (P; 200 nM, 5 min), thapsigargin (T; 200 nM, 30 min) a combination blotting. A 100 kDa tyrosine-phosphorylated protein binds to Grb2 in of ionomycin (5 μM, 2 min) and EGTA (3 mM, 1 min) (I/E) or a PTX-sensitive manner. (B) Serum-starved Rat-1 cells were treated ionomycin alone (I; 50 nM). Tyrosine phosphorylation state of the Shc with the indicated agonists with or without prior pre-treatment with proteins was assayed by anti-Shc immunoprecipitation followed by PTX. Induction of the p100-Grb2 interaction was then assayed as in anti-phosphotyrosine immunoblotting. Both PKC activation and (A). (C) Serum-starved cells were either left untreated or were elevation of intracellular Ca 2ϩ causes tyrosine phosphorylation of Shc.
pre-treated with either genistein (G; 50 mM, 30 min), staurosporine Serum-starved COS cells were incubated with either PdBU (200 nM, (S; 100 nM, 10 min) or wortmannin (W; 100 nM, 10 min). After LPA overnight), thapsigargin or EGTA/ionomycin prior to stimulation with stimulation, induction of p100-Grb2 interaction was determined as in either LPA (B) or EGF (C) and Shc tyrosine phosphorylation was (A). All three agents inhibit both LPA-induced MAP kinase activation assayed as in (A).
( Figure 1 ) and p100-Grb2 complex formation. (D) LPA-induced binding of tyrosine-phosphorylated proteins to the various domains of Grb2. Binding of cellular proteins to 2 μg of the indicated fusion thrombin and serum (which contains LPA; Moolenaar, proteins was assayed as in (A). p100 preferentially binds to the 1995b) also induce p100-Grb2 complex formation ( Figure   C -terminal SH3 domain of GST-Grb2, as does p90, whereas p110 binds to the N-terminal SH3 domain. 6B). In marked contrast, the peptide endothelin, which activates the G q /PLC but not the G i /Ras pathway in Rat-1 cells, fails to induce p100-Grb2 complex formation. with any of these inhibitors prevents p100-Grb2 complex formation upon LPA stimulation ( Figure 6C ). In some We were unable to assess whether the Grb2-100 complex is also induced by EGF, because of the many bands experiments we observed two additional tyrosine-phosphorylated proteins of~90 and 110 kDa (p90 and p110) present in the 100-120 kDa region upon EGF stimulation ( Figure 6B ). Among the multiple tyrosine-phosphorylated that also bind to Grb2 in response to LPA. However, although inhibited by genistein and staurosporine, the latter Grb2 binding proteins in this region, we identified the p120 cbl proto-oncogene product (cf. Galisteo et al., 1995;  interactions are insensitive to either PTX or wortmannin ( Figure 6B and C). We conclude that p100-Grb2, but not Meisner and Czech, 1995) . However, tyrosine-phosphorylated c-Cbl was not detected in LPA-stimulated cells; we p90-Grb2 or p110-Grb2, lies on the route from G i to Ras/ MAP kinase activation in fibroblasts. also excluded the possibility that p100 is an isoform of dynamin, a Grb2 binding GTPase involved in receptormediated endocytosis (Wang and Moran, 1996;  p100 preferentially binds to the C-terminal SH3 domain of Grb2 O.Kranenburg and I.Verlaan, unpublished observations).
We next examined the effects of genistein, staurosporine Finally, we examined which Grb2 domain(s) mediates interaction with p100. Figure 6D shows the triplet of and wortmannin, at doses that inhibit G i -mediated MAP kinase activation (cf. Figure 1) . Treatment of the cells tyrosine-phosphorylated proteins that bind to full-length Grb2 in response to LPA, with the strongest signal tyrosine kinase to activate MAP kinase in response to LPA or bradykinin . corresponding to p100. Using three different GST-Grb2 deletion mutants, we found that p100 preferentially binds
In contrast to the situation with G protein-coupled receptors, Src family kinases are required for PDGF and to the C-terminal SH3 domain of Grb2 in an LPAdependent manner ( Figure 6D ), although it is seen that EGF receptor mitogenic signaling (Roche et al., 1995; Broome and Hunter, 1996; Erpel et al., 1996) , where they there is also some binding affinity for the N-terminal SH3 domain of Grb2. We further note that p110 also binds to may control the transcriptional activation of Myc in a Ras-independent manner . the C-terminal Grb2-SH3 domain, whereas p90 binds only to N-terminal Grb2-SH3 ( Figure 6D) . No detectable G protein-regulated Src activation is likely to play a role in non-mitogenic events mediated by PTX-insensitive G q/11 interaction was observed with the isolated SH2 domain of Grb2 ( Figure 6D) . and/or G 12/13 , such as cytoskeletal remodeling and gap junction closure (F.Postma, T.Hengeveld, J.Alblas, G.Zondag and W.Moolenaar, submitted for publication).
Discussion Daub et al. (1996) suggested that transactivation of the EGF receptor links G protein-coupled receptors to RasThe present study provides new insights into the signaling events that link G i -coupled receptors to activation of the dependent MAP kinase activation in Rat-1 cells. Inconsistent with their model, the authors found strong EGF Ras/MAP kinase pathway. We have built on previous data showing that G i -mediated Ras/MAP kinase activation in receptor activation by endothelin, which fails to activate Ras as well as MAP kinase in Rat-1 cells, as mentioned fibroblasts stimulated by either LPA or thrombin involves genistein-and staurosporine-sensitive tyrosine kinase above. In agreement with others using PC12 cells , we have been unable to detect LPA-induced activity Hordijk et al., 1994) . Subsequent studies have shown that the G i /Ras/MAP phosphorylation of the EGF receptor in both Rat-1 and COS cells (data not shown). Furthermore, it is noteworthy kinase cascade is initiated by βγ subunits and involves not only protein tyrosine kinase activity but also a wortmanninthat EGF-and LPA-induced MAP kinase activation show differential sensitivity to tyrosine kinase inhibitors sensitive PI 3-kinase; these steps somehow lead to recruitment of the Grb2 adaptor protein, which targets the ( Figure 1 ). nucleotide exchanger Sos to Ras at the plasma membrane (for references see Introduction).
Shc phosphorylation
The adaptor protein Shc participates in a network of Using LPA and thrombin as prototypic agonists, we have established that, contrary to previous views, G iprotein-protein interactions not necessarily leading to Ras activation (Bonfini et al., 1996) . We have shown that Shc coupled receptors utilize neither Src nor tyrosine-phosphorylated Shc to activate the Grb2-mediated Ras/MAP tyrosine phosphorylation is not involved in G i -mediated MAP kinase activation. First, although LPA-induced tyrokinase pathway in fibroblasts and COS cells. Instead, we find a tyrosine-phosphorylated 100 kDa protein (p100) sine phosphorylation of Shc is detectable in COS cells, PTX does not inhibit this response under conditions where that binds to the C-terminal SH3 domain of Grb2 and meets the criteria for linking G i to Ras/MAP kinase MAP kinase activation is blocked. Second, expression of the dominant-negative Shc-SH2 domain (Baldari et al., activation. 1995) has no effect on LPA-induced MAP kinase activation, whereas the response to EGF is significantly attenuSrc activation Our conclusion that G protein-mediated Src activation is ated. Finally, in Rat-1 cells, LPA-induced MAP kinase activation occurs in the absence of detectable tyrosine not involved in MAP kinase activation is based on the following findings: (i) transient or stable expression of phosphorylation of Shc. In agreement with this finding, a recent study showed that a transfected G i -coupled receptor dominant-negative Src in COS cells or Rat-1 cells respectively does not interfere with LPA-induced MAP kinase mediates MAP kinase activation in the absence of Shc phosphorylation in mouse fibroblasts (Torres and Ye, activation; (ii) LPA-induced Src activation, as inferred from complex formation with p110 and p130, is insensitive 1996). LPA-induced Shc phosphorylation in COS cells is mimicked by Ca 2ϩ ionophore and phorbol ester and, to PTX and hence not downstream of G i ; (iii) the G qcoupled endothelin receptor mediates activation of c-Src, furthermore, is abrogated in Ca 2ϩ -depleted cells. This suggests that LPA-induced tyrosine phosphorylation of but not that of Ras nor MAP kinase (Figure 2 ; van Corven et al., 1993; Hordijk et al., 1994) ; (iv) LPA-induced Shc is secondary to G q -mediated inositol lipid breakdown. MAP kinase activation is readily detected in Src-deficient fibroblasts ( Figure 2E ). Our conclusion is supported by a p100-Grb2 interaction In an effort to identify tyrosine-phosphorylated signaling previous report showing that Src family kinases are not required for LPA-induced DNA synthesis in 3T3 cells intermediates involved in Grb2 recruitment, we have detected several tyrosine-phosphorylated proteins that bind (Roche et al., 1995) .
A recent report showed that transient overexpression of to Grb2 in an agonist-dependent manner. Of these, only p100 associates with Grb2 in a PTX-sensitive manner. In the C-terminal Src kinase (CSK), a negative regulator of Src family kinases, inhibits LPA-induced Shc phosphorylother words, p100 is part of a G i -mediated signaling cascade. Furthermore, pre-treatment of cells with any of ation and MAP kinase activation in COS cells (Luttrel et al., 1996) ; dominant-negative Src was not used in that the pharmacological inhibitors of LPA-induced Ras/MAP kinase activation (genistein, staurosporine and wortmanstudy. We have no explanation for the discrepancy with the present results. In PC12 neuronal cells, Src family nin) precludes detection of Grb2-associated p100. The wortmannin sensitivity is of note, as it supports kinases may act in concert with the cell type-specific Pyk2 the consecutive activation of a wortmannin-sensitive PI 3-kinase (most likely the γ isoform) and a non-Src tyrosine kinase. As a result of phosphatidylinositol 3-phosphate production in the plasma membrane, tyrosine kinase activity might be recruited (see for example Rameh et al., 1995) , which then phosphorylates p100. This may then lead to cooperative binding between p100 and the SH2 and SH3 domains of Grb2. Although we do not observe association of the isolated Grb2-SH2 domain with p100, it may well be that SH3-p100 interaction is required
The βγ subunits released from G i are proposed to activate the γ-isotype of PI 3-kinase, which then may lead to recruitment of an for enhanced binding through phosphotyrosine-Grb2-SH2 SH2 domain-containing protein tyrosine kinase. This non-Src tyrosine interaction. In a parallel but independent pathway, G qkinase phosphorylates p100, presumably leading to an enhanced mediated activation of PLC causes PKC activation and affinity of p100 for Grb2. With Grb2, SOS is translocated to the Ca 2ϩ mobilization, somehow leading to enhanced tyrosine plasma membrane to promote GDP/GTP exchange on Ras, leading to activation of the MAP kinase cascade. In a parallel but independent kinase activity and subsequent tyrosine phosphorylation pathway, activated G q α stimulates PLC activity, leading to PKC of Shc. Whether Src also participates in G q -mediated activation and Ca 2ϩ release, followed by tyrosine phosphorylation of signaling is currently not clear. Our future experiments Shc. Whether Src also functions in the G q pathway remains to be are directed towards establishing the identity of p100 and established. For details see text.
the kinase that mediates its tyrosine phosphorylation. the notion that the tyrosine phosphorylation step requires
Materials and methods
upstream PI 3-kinase activity (Hawes et al., 1996 ; see also Pace and Bourne, 1995) . Antibody microinjection Cell culture and transfection experiments in fibroblasts suggest that the α isoform of COS-7, Rat-1 cells and immortalized Src-deficient fibroblasts (Bockholt and Burridge, 1995) were routinely grown in Dulbecco's modified Eagle's PI 3-kinase is not required for LPA mitogenic signaling medium containing 8% fetal calf serum and antibiotics. Transfection of (Roche et al., 1994) . Furthermore, constitutively activated COS-7 cells was performed by the DEAE method. After transfection PI 3-kinase α activates Jun kinase and the p70 S6 kinase, cells were exposed to serum-free medium overnight. Before stimulation of but not MAP kinase in COS cells (Klippel et al., 1996) .
